Liang Y, Wei H, Yu X, Huang W, Luo X P
Department of Pediatric, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Zhonghua Er Ke Za Zhi. 2017 Feb 2;55(2):125-130. doi: 10.3760/cma.j.issn.0578-1310.2017.02.014.
To explore the clinical characteristics of diagnosis and treatment in patients with Turner syndrome and rapidly progressive puberty. A rare case of rapidly progressive puberty in Turner syndrome with a mosaic karyotype of 45, X/46, X, del(X)(p21)(80%/20%)was diagnosed at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology in January. 2015. Clinical characteristics and the related literature were reviewed. Original papers on precocious puberty or rapidly progressive puberty in Turner syndrome, published until Apr. 2016 were retrieved at PubMed and CNKI databases by the use of the key words "Turner syndrome" , "precocious puberty" and "rapidly progressive puberty" . The patient was born at term with birth weight of 2 450 g and was diagnosed with SGA at 3 years of age for the first evaluating of growth and development. Then recombined human growth hormone (rhGH )was given at 4 years of age due to short stature (height<3 percentile) and low growth velocity(<5.0 cm/year) as well. However, rhGH treatment was discontinued after 9 months because of economic burdens. Breast development was noted at 9 years and 3 months. The patient was followed up at 3 months intervals. Physical examination revealed a Tanner stage Ⅲ breast development at 10.33 years , the bone age was 11.6 years. Then, gonadotropin-releasing hormone analogs treatment was added to slow pubertal progression and to preserve maximum adult height. The growth rate decreased with therapy from 7.5 cm/year to 4.4 cm/year. The patient was reevaluated, and the chromosome analysis of peripheral blood revealed a mosaic karyotype 45, X/46, X, del(X)(p21)(80%/ 20%). To date, only 10 cases have been reported in the literature. Six of them showing mosaic TS, three karyotypes with structural abnormality of short arm of X chromosome, one with the karyotype 45, X. It is the first time that rapidly progressive puberty in a 45, X/46, X, del(X)(p21) mosaic Turner syndrome is reported. Although short stature and ovarian dysgenesis are common in TS, precocious puberty may occur in TS, which is liable to cause delayed diagnosis and misdiagnosis. Careful examination is recommended for patients with unusual growth pattern, even though girls have normal height in accord with standard growth curve or spontaneous puberty. Evaluation for TS and subsequent investigation should be prompted.
探讨特纳综合征合并快速进展性青春期患者的临床诊断与治疗特点。2015年1月,华中科技大学同济医学院附属同济医院诊断出1例核型为45,X/46,X,del(X)(p21)(80%/20%)的特纳综合征合并快速进展性青春期的罕见病例。回顾其临床特点及相关文献。通过在PubMed和CNKI数据库中检索关键词“特纳综合征”“性早熟”和“快速进展性青春期”,收集截至2016年4月发表的关于特纳综合征性早熟或快速进展性青春期的原始文献。该患者足月出生,出生体重2450g,3岁首次评估生长发育时被诊断为小于胎龄儿。4岁时因身材矮小(身高<第3百分位数)且生长速度缓慢(<5.0cm/年)开始给予重组人生长激素(rhGH)治疗。然而,9个月后因经济负担停止rhGH治疗。9岁3个月时发现乳房发育。此后每3个月随访1次。体格检查显示,10.33岁时乳房发育达坦纳Ⅲ期,骨龄为11.6岁。随后加用促性腺激素释放激素类似物治疗以减缓青春期进展并保留最大成年身高。治疗后生长速度从7.5cm/年降至4.4cm/年。再次评估时,外周血染色体分析显示核型为45,X/46,X,del(X)(p21)(80%/20%)。迄今为止,文献中仅报道过10例。其中6例为嵌合型特纳综合征,3例核型为X染色体短臂结构异常,1例核型为45,X。本文首次报道45,X/46,X,del(X)(p21)嵌合型特纳综合征合并快速进展性青春期。虽然身材矮小和卵巢发育不全在特纳综合征中很常见,但性早熟也可能发生,这容易导致诊断延迟和误诊。对于生长模式异常的患者,即使女孩身高符合标准生长曲线或青春期发育正常,也建议进行仔细检查。应及时对特纳综合征进行评估及后续检查。